Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility

Robbert D. A. Weren, Rachel S. van der Post, Ingrid P. Vogelaar, J. Han van Krieken, Liesbeth Spruijt, Jan Lubinski, Anna Jakubowska, Urszula Teodorczyk, Cora M. Aalfs, Liselotte P. van Hest, Carla Oliveira, Eveline J. Kamping, Hans K. Schackert, Guglielmina N. Ranzani, Encarna B. Gomez Garcia, Frederik J. Hes, Elke Holinski-Feder, Maurizio Genuardi, Margreet G. E. M. Ausems, Rolf H. SijmonsAnja Wagner, Lizet E. van der Kolk, Annemieke Cats, Inga Bjornevoll, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)669-674
Number of pages6
JournalJournal of Medical Genetics
Volume55
Issue number10
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • cancer: gastric
  • heritability
  • ctnna1-map3k6-myd88
  • next generation sequencing
  • MOLECULAR INVERSION PROBES
  • MUTATIONS
  • CDH1
  • GUIDELINES
  • CARCINOMAS
  • ACCURACY

Cite this

Weren, R. D. A., van der Post, R. S., Vogelaar, I. P., van Krieken, J. H., Spruijt, L., Lubinski, J., Jakubowska, A., Teodorczyk, U., Aalfs, C. M., van Hest, L. P., Oliveira, C., Kamping, E. J., Schackert, H. K., Ranzani, G. N., Garcia, E. B. G., Hes, F. J., Holinski-Feder, E., Genuardi, M., Ausems, M. G. E. M., ... Ligtenberg, M. J. L. (2018). Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. Journal of Medical Genetics, 55(10), 669-674. https://doi.org/10.1136/jmedgenet-2017-104962